Maria C. Walker
CIK: 0001826519
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Walker Maria C
Walker Maria C (SEC CIK 0001826519) files insider reports with the SEC as Director of MapLight Therapeutics, Inc. (MPLT) and Director of Five9, Inc. (FIVN).
Signal8 holds 4 ownership filings by Walker Maria C (1 Form 3, 3 Form 4), filed between Oct 27, 2025 and Jun 25, 2026. Those filings report 3 transactions, from Oct 27, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Walker Maria C's filings is in REDWOOD CITY, CA.
Recent filings by Walker Maria C
Other insiders filing for MapLight Therapeutics, Inc. (MPLT)
- Kreitzer Anatol, Chief Discovery Officer
- GILLIS JONATHAN, CAO and Interim CFO
- Lillie James Woodruff, Chief Scientific Officer
- Hanson Kristopher, General Counsel
- Foff Erin Pennock, Chief Medical Officer
- Kroeger Christopher A., Chief Executive Officer